IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 3-ready biotech developing microbiome therapeutics.
Industry: Health Care
Latest Trade: $2.32 0.00 (0.0%)
First Day Return: +25.4%
Return from IPO: -99.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/26/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $128 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/18/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $128 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
BofA Securities |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Somerville, MA, United States |
Founded | 2014 |
Employees | 131 |
Website www.finchtherapeutics.com |